# Risk: __Lack of medication and vaccines for COVID-19__ (PBN__Risk_1495)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskTechnology

* [pharmaceutical companies](../Technology/PBN__Technology_763)
* [research institutions](../Technology/PBN__Technology_314)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)
* [healthcare workers](../Stakeholder/PBN__Stakeholder_68)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskISO_Purpose

* [Safety and security](../RiskISO/PBN__RiskISO_Impact_0)

## Property: has_RiskOwner

* [pharmaceutical companies](../Stakeholder/PBN__Stakeholder_124)
* [government agencies](../Stakeholder/PBN__Stakeholder_55)

## Property: has_RiskMitigation

* [Develop and distribute effective medications and vaccines.](../RiskMitigation/PBN__RiskMitigation_2016)

## Property: has_RiskName

High morbidity and mortality rates, prolonged pandemic, strain on healthcare systems.

## Property: has_RiskDescription

There is currently no medication or vaccine available for COVID-19, leaving the population vulnerable to the virus.

## Property: has_RiskSource

* [hutasoit_sars-cov-2_2020](../Article/PBN__Article_16)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

